The EPS beat and raised guidance are the headline positives, but the revenue miss vs consensus and the narrowing of revenue guidance (due to the SES JV) warrant monitoring. Watch the Q4 earnings call for organic growth trajectory and integration progress of Entrust.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $134.72entry
- T+1 · 13d ago +0.71%α −0.94% · $135.68
- T+5 · 7d ago +1.87%α +2.46% · $137.24
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Leidos reported Q3 FY2026 revenue of $4.63B (up 4% YoY) and non-GAAP diluted EPS of $3.62 (up 19% YoY), beating the consensus EPS estimate of $3.04. The company raised its full-year non-GAAP EPS guidance to $12.50-$12.70 (from $12.20-$12.50) and narrowed revenue guidance to $18.00B-$18.20B, reflecting strong operational momentum and the contribution from the Entrust acquisition.
Key Financial Metrics
Key Facts
- Revenue of $4.63B, up 4% YoY, vs consensus $4.71B (slight miss on top line)
- Non-GAAP diluted EPS of $3.62, up 19% YoY, vs consensus $3.04 (beat by 19.1%)
- GAAP diluted EPS of $3.28, up 16% YoY
- Adjusted EBITDA of $644M, up 5% YoY; margin 13.9% vs 13.8%
- Operating cash flow of $523M; free cash flow of $476M
- Net bookings of $5.5B (book-to-bill 1.2); total backlog $49.6B, funded backlog $11.1B
- Full-year non-GAAP EPS guidance raised to $12.50-$12.70 from $12.20-$12.50
- Full-year revenue guidance narrowed to $18.00B-$18.20B from $18.20B-$18.40B
- Cash dividend increased 4.7% to $0.45 per share
- Closed contribution of SES businesses to a joint venture with Altaris on Oct 5, 2026
Financial Impact
Non-GAAP EPS beat consensus by $0.58 (19.1%); full-year EPS guidance midpoint raised $0.25 to $12.60; revenue guidance midpoint reduced $0.20B to $18.10B reflecting the SES joint venture contribution
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Intelligence Digital | $1.5B | +1.4% |
| Health | $1.1B | -11.7% |
| Homeland | $1.0B | +32.1% |
| Defense | $992.0M | +3.4% |
Risk Factors
- Revenue of $4.63B missed consensus of $4.71B by 1.7%
- Health segment revenue declined 12% YoY with margin compression (22.5% vs 26.8%)
- Debt increased to $6.0B from $4.6B at year-end, reflecting Entrust acquisition financing
- Organic revenue growth was only 0.6% after adjusting for acquisitions and divestitures
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001336920-26-000290 |
| Document: ldos-20261103.htm | 0001336920-26-000290 |
| Document: 0001336920-26-000290-index-headers.html | 0001336920-26-000290 |
| Document: 0001336920-26-000290-index.html | 0001336920-26-000290 |
| Document: 0001336920-26-000290.txt | 0001336920-26-000290 |
| 8-K Data (Synthetic) | 0001336920-26-000290 |
Track record
38 reports on LDOS
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +14.62% at T+20 after the Sep 29, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 Viewing Entry $134.72 Now $130.02 −3.49% settles Dec 2
- Oct 30, 202617d ago Press Release Neutral 2/10 Entry $144.16 Now $130.02 −9.81% settles Dec 1
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $136.08 Now $130.02 −4.45% settles Nov 20
- Oct 14, 20264w ago Press Release Neutral 3/10 Entry $120.59 to $133.89 Now $130.02 +7.82% ▲ +11.03% +12.30% vs SPY
- Oct 13, 20265w ago GOVT-CONTRACT Neutral 3/10 Entry $120.59 to $133.89 Now $130.02 +7.82% ▲ +11.03% +12.30% vs SPY
- Oct 6, 20265w ago Press Release Neutral 1/10 Entry $116.69 Now $130.02 +11.42% No price data
- Oct 5, 20266w ago 8-K Neutral 5/10 Entry $119.45 to $142.98 Now $130.02 +8.85% ▲ +19.70% +22.16% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $121.97 to $141.02 Now $130.02 +6.60% ▲ +15.62% +14.92% vs SPY
- Oct 1, 20266w ago GOVT-CONTRACT Neutral 2/10 Entry $117.74 to $142.98 Now $130.02 +10.43% ▲ +21.44% +23.25% vs SPY
- Oct 1, 20266w ago GOVT-CONTRACT Neutral 3/10 Entry $117.74 to $142.98 Now $130.02 +10.43% ▲ +21.44% +23.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers